Gilde Healthcare - Wiki

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million under management and looks to invest in digital health, diagnostics, medical devices, therapeutics and healthcare services. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

Investment

Glide Healthcare Partners' investments include AM Pharma, SANIFIT, CVRx, Vesper Medical, Calypso Biotech, Lumeon, Vapotherm, Lava Therapeutics, Axonics Modulation Technologies and Inari Medical.

Their exited investments include Evotec, Axonics Modulation Technologies, Innate Pharma, Vapotherm, Ascendis Pharma, Galapagos, Ablynx, Definiens and Breath Therapeutics.

Timeline

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title

Author

Link

Type

Date

News

Title

Author

Date

Publisher

Description

Spire Health Closes $38 Million Financing Round Led by Gilde Healthcare to Advance Respiratory Remote Patient Monitoring

July 14, 2021

WebWire

Spire Health, the leading provider of respiratory remote patient monitoring (RPM), today announced the closing of a $38 million equity financing, led by Gilde Healthcare Partners along with a leading global medtech strategic partner. Geoff Pardo, General Partner at Gilde Healthcare, will join Spire's Board of Directors. Spire Health was advised by JMP Securities LLC in the transaction. The new capital will enable Spire to expand commercialization of its unique respiratory remote patient m...

BioSpace Movers & Shakers, June 4

Alex Keown

June 4, 2021

BioSpace

Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

Adcendo raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers

Adcendo

April 29, 2021

www.prnewswire.com:443

/PRNewswire/ -- Adcendo, a biotech company developing antibody-drug conjugates (ADCs) for the treatment of cancers, today announced the successful closing of a...

Health tech funding snapshot--Withings nabs $60M to expand into healthcare; Ro raises $200M

Heather Landi

September 1, 2020

FierceHealthcare

Withings, a French company widely known for its connected consumer health devices, has been pushing further into the healthcare industry. SoftBank's second Vision Fund led a $250 million investment in a drug delivery startup. Anthem is backing digital primary care service K Health, and more funding news.

gildehealthcare.com

Is a

Organization